1,024 material Form 8-K filings that 832 companies we cover made with the SEC in February 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
On February 19, 2025, ADMA Biologics' board approved 2025 base salaries, 2024 cash bonuses and new equity awards for CEO Adam S. Grossman, COO Kaitlin Kestenberg and CFO Brad Tade. The board also approved a higher annual equity grant policy and higher committee retainers for non-employee directors, effective January 1, 2025.
Grossman's 2025 base salary is $925,000 and his 2024 non-equity incentive compensation is $1,020,000.
Grants made February 19, 2025 at $16.07 per share, the Nasdaq closing price on the grant date, include 252,022 RSUs and 376,744 options for Grossman.
Non-employee directors will receive $350,000 of annual long-term incentive value, split 50% RSUs and 50% options.
Audit Committee chair retainer rises to $25,000 from the filing's stated levels, effective January 1, 2025.
Roivant Sciences said Rakhi Kumar stepped down as Principal Accounting Officer and Chief Accounting Officer of its subsidiary Roivant Sciences, Inc., effective February 20, 2025. Jennifer Humes, a former JPMorgan Chase Managing Director, was appointed to both roles from the same date. The change affects the company's principal accounting officer, a role responsible for financial reporting, but the filing reports no financial results.
Rakhi Kumar stepped down effective February 20, 2025, and the company thanked her for her service.
Jennifer Humes was appointed Principal Accounting Officer and Chief Accounting Officer of RSI effective February 20, 2025.
Humes's offer letter includes a $380,000 base salary, a $190,000 target annual cash bonus, and a $261,500 sign-on bonus.
Equity grants have estimated values of approximately $1.2 million in RSUs and $800,000 in stock options, vesting over multiple years.
On February 18, 2025, L3Harris entered a new $2.5 billion, five-year senior unsecured revolving credit facility with JPMorgan Chase Bank as administrative agent, replacing its prior $2 billion facility from July 29, 2022, which the company says incurred no early termination penalties. The company also set up a new $500 million, 364-day revolving facility to replace a $1.5 billion facility that matured on January 24, 2025. The filing describes the terms of these refinancings and does not state any amounts drawn under them, and the excerpt ends partway through Item 2.03.
New $2.5 billion revolver matures February 18, 2030, with a possible one-year extension under certain circumstances.
Prior $2 billion facility dated July 29, 2022 was terminated; the filing says no early termination penalties were incurred.
New $500 million 364-day facility commitments run through February 17, 2026, replacing a $1.5 billion facility that matured January 24, 2025.
Initial interest margin on the $2.5 billion facility is 1.125% over term SOFR, adjustable based on L3Harris senior debt ratings.
At meetings on February 19-20, 2025, the board and its Compensation and Human Capital Committee approved annual 2025 pay increases for CEO Mark Tarr and three other named executive officers. For Tarr, base salary rises to $1.1 million, target cash bonus to $1.485 million, and target long-term equity to $6 million, and his annual personal aircraft-use allowance rises from approximately $75,000 to $100,000. The filing describes these as routine annual decisions and does not report any change in financial results, but the higher pay levels add to executive compensation costs.
Tarr's base salary rises from $1,050,000 to $1,100,000; target cash bonus from $1,260,000 to $1,485,000; target long-term equity from $5,425,000 to $6,000,000.
Tarr's annual personal aircraft-use allowance rises from approximately $75,000 to $100,000.
CFO Douglas Coltharp's base salary rises from $700,000 to $750,000; target long-term equity from $1,925,000 to $2,250,000.
Decisions were made at February 19-20, 2025 meetings, on the recommendation of the Compensation and Human Capital Committee and its independent consultant.
On February 18, 2025, SLM's Compensation Committee approved a 25 percentage point increase to Executive Vice President and Chief Commercial Officer Donna F. Vieira's target annual incentive bonus under the 2025 Annual Incentive Plan, from 125% to 150% of her base salary. The company said the change keeps her pay competitive with the market and ties more of her compensation to fiscal 2025 performance. The filing covers only this compensation change and reports no financial results.
Target annual incentive bonus raised from 125% to 150% of annual base salary, an increase of 25 percentage points.
Approved by the Compensation Committee of the Board on February 18, 2025, under the 2025 Annual Incentive Plan.
Change is for Donna F. Vieira, Executive Vice President and Chief Commercial Officer.
Filing dated February 21, 2025 and signed by Nicolas Jafarieh, Executive Vice President and Chief Legal, Government Affairs, and Communications Officer.
Penumbra said director Don Kassing notified the company on February 14, 2025 that he will retire from its board effective April 1, 2025. The filing states his decision did not involve any disagreement with the company, and it contains no financial results or guidance.
Don Kassing, a board member since 2008 and Presiding Director since 2015, will retire effective April 1, 2025.
Notice to the company was dated February 14, 2025; the press release was issued February 21, 2025.
Board chair, president and CEO Adam Elsesser thanked Kassing for his service over 17 years.
The filing states Kassing's decision did not involve any disagreement with the company.
Weyerhaeuser appointed Alex G. Whitney, its vice president and controller, as vice president and chief accounting officer, effective February 18, 2025. David Wold, senior vice president and chief financial officer, stops serving as principal accounting officer on the same date, having held that role since May 17, 2019. The change is an internal accounting leadership appointment, and the filing discloses no change to financial results or guidance.
Board appointed Alex G. Whitney, age 37, on February 14, 2025; effective date February 18, 2025
Whitney joined the company in September 2019 and has been vice president and controller since May 2022
Whitney's 2024 pay included a $257,500 base salary, a 35% annual cash incentive target, and $121,000 in restricted stock units; 2025 pay is expected to be materially consistent
Eastman Chemical issued $250 million of 5.000% notes due August 1, 2029, in a public offering, adding to $500 million of the same notes issued in August 2024. The company expects net proceeds of about $246.2 million for general corporate purposes, including working capital, capital expenditures and debt repayment.
Notes: $250 million principal, 5.000% coupon, maturing August 1, 2029, issued February 21, 2025
Expected net proceeds of approximately $246.2 million after underwriting discounts and offering expenses
Underwriting Agreement dated February 18, 2025, with BofA Securities and J.P. Morgan Securities as representatives
Notes form a single series with the $500 million of 5.000% notes issued August 1, 2024
HP Inc. expanded its board from 14 to 15 seats and elected Gianluca Pettiti, Executive Vice President and President of Life Sciences, Diagnostics and Applied at Thermo Fisher Scientific, as an independent director on February 21, 2025. He was also named to the Finance, Investment and Technology Committee and the HR and Compensation Committee, and will receive standard non-employee director pay.
Board size increased from 14 to 15 directors, effective February 21, 2025
Pettiti receives an annual cash retainer of $105,000 and an annual equity retainer of $220,000, pro-rated for his first partial year
Pettiti joins the Finance, Investment and Technology Committee and HR and Compensation Committee
On February 19, 2025, Molina Healthcare entered a third amendment to its credit agreement with Truist Bank as administrative agent, which amends and restates the prior agreement dated June 8, 2020. The amendment adds a $500 million delayed draw commitment that can be drawn for general corporate purposes if the company meets pro forma financial covenants. For shareholders, this adds committed borrowing capacity, though the filing does not say whether any amount has been drawn.
Third amendment dated February 19, 2025, with Truist Bank as administrative agent; prior agreement dated June 8, 2020
$500 million delayed draw commitment, available until June 19, 2025, with a maturity date of February 19, 2027
Applicable margin of 0.125% for base rate loans and 1.125% for SOFR-based loans; ticking fee of 0.25% per annum on the unused commitment
HCA Inc., a wholly owned subsidiary of HCA Healthcare, completed a public offering of $5.25 billion in senior notes on February 21, 2025, across six tranches maturing between 2028 and 2055. The notes are guaranteed on a senior unsecured basis by HCA Healthcare, and the filing adds $5.25 billion of direct financial obligations to the company's debt.
Six tranches total $5.25 billion: $700 million 5.000% notes due 2028, $300 million floating rate notes due 2028, $750 million 5.250% notes due 2030, $750 million 5.500% notes due 2032, $1.5 billion 5.750% notes due 2035 and $1.25 billion 6.
Interest on the fixed-rate notes is payable semi-annually on March 1 and September 1, starting September 1, 2025
The notes were sold under a shelf registration filed May 1, 2023, with underwriters including BofA Securities, Barclays and J.P. Morgan, under an underwriting agreement dated February 18, 2025
Pool Corporation disclosed that Kristopher R. Neff left his position as Vice President, Strategy and Corporate Development, effective February 18, 2025. The filing does not give a reason for the departure or name a successor, and it contains no financial results.
Kristopher R. Neff departed as Vice President, Strategy and Corporate Development on February 18, 2025.
The filing was signed February 21, 2025, by Jennifer M. Neil, Senior Vice President, Secretary and Chief Legal Officer.
The 8-K does not state a reason for the departure or name a replacement.
On February 20, 2025, TransMedics, Inc., a wholly-owned subsidiary of TransMedics Group, Inc., bought one fixed-wing aircraft from Ocean Select Seafood, L.L.C. for approximately $14.3 million. The filing says the company intends to use all 21 aircraft it has acquired to date to transport donor organs under its National OCS Program, and it treats the purchases as a series of related transactions. The filing reports no revenue, profit, or guidance figures, so its effect on shareholders is limited to the added spending and fleet.
Aircraft purchased February 20, 2025, from Ocean Select Seafood, L.L.C. for approximately $14.3 million
Brings the total to 21 aircraft acquired to date, including 20 in prior acquisitions reported in 13 earlier 8-K filings
Aircraft are intended for transporting donor organs as part of the National OCS Program
On February 14, 2025, PNC's Human Resources Committee approved changes to restricted and performance share unit awards for Section 16 officers. Under the revised terms, awards that remain outstanding after a qualifying termination without cause or for good reason continue to vest and pay out as if the officer had stayed employed through the full vesting or performance period.
Change approved by the Human Resources Committee on February 14, 2025, under the 2016 Incentive Award Plan
Applies to restricted share unit (RSU) and performance share unit (PSU) awards held by Section 16 officers
Continued vesting is subject to the grantee's ongoing compliance with award terms and applicable risk adjustments
Filing does not state any dollar amounts or share counts affected
Deluxe Corporation's board elected Morgan M. "Mac" Schuessler, Jr., CEO, President and director of Evertec Group, as an independent director effective February 21, 2025. He was also assigned to the Audit and Finance and Corporate Governance Committees, effective April 23, 2025, alongside new director Hugh S. Cummins. The filing reports no financial results, and the board change is administrative in nature for shareholders.
Schuessler elected to the board by unanimous vote on February 20, 2025, effective February 21, 2025, and will stand for re-election at the 2025 Annual Meeting
Board determined Schuessler is independent under NYSE listing standards and company independence standards
Schuessler has been CEO, President and director of Evertec Group since 2015 and previously served as President, International, at Global Payments from 2005 to 2014
Committee assignments for Schuessler and Hugh S. Cummins take effect April 23, 2025
Exelon sold $1.0 billion of senior notes on February 21, 2025, split into $500 million of 5.125% notes due 2031 and $500 million of 5.875% notes due 2055. Part of the proceeds, with available cash, will repay $464 million of commercial paper borrowings that carried a weighted average rate of 4.537% as of February 11, 2025, and the rest will fund general corporate purposes. The filing describes a financing transaction that adds long-term debt rather than a change to operations or earnings.
Notes: $500 million of 5.125% due March 15, 2031 and $500 million of 5.875% due March 15, 2055
Interest paid semi-annually on March 15 and September 15, starting September 15, 2025
$464 million of proceeds plus cash on hand to repay commercial paper at about 4.537% weighted average rate
Lakeland Financial Corporation appointed Stephanie R. Leniski as Executive Vice President and Chief Retail Banking Officer of the Company and its subsidiary Lake City Bank. The Company entered into a Change in Control Agreement with her on February 19, 2025, on the same form used for certain named executive officers. The filing contains no financial results, and the role's compensation terms beyond this agreement are not stated.
Stephanie R. Leniski named Executive Vice President and Chief Retail Banking Officer of Lakeland Financial and Lake City Bank
Change in Control Agreement entered into on February 19, 2025, filed as Exhibit 10.1
Agreement uses the same form as certain named executive officers; summary is in the 2024 proxy statement filed February 29, 2024
On February 17, 2025, Helix Energy Solutions Group and its OneSubsea and Schlumberger affiliates signed an amendment to their strategic alliance for subsea well intervention systems. The amendment extends the agreement's ten-year term by one year, to January 5, 2026, and reflects Cameron Lux V Sarl as successor to OneSubsea B.V. The filing discloses no financial terms, so the effect on Helix's results is not quantified.
Amendment dated February 17, 2025 extends the Alliance Agreement by one year, to January 5, 2026.
The original Strategic Alliance Agreement was entered into January 5, 2015 and provided a ten-year term.
Cameron Lux V Sarl is named as successor in interest to OneSubsea B.V.
The filing does not disclose financial terms of the amendment.
Bruker Corporation's Board increased its size by one seat to ten directors and appointed Laura Francis, CEO of SI-BONE, Inc., to fill the new vacancy effective February 18, 2025. The filing says she will join the Audit Committee after the 2025 annual meeting and that her director pay will match other non-employee directors.
Laura Francis appointed director effective February 18, 2025, serving until the 2026 Annual Meeting of Stockholders
Board expanded from nine to ten directors, with the new seat assigned to Class II
Francis expected to join the Audit Committee as a financial expert after the end of May 2025 annual meeting
Francis is CEO and a board member of SI-BONE, Inc. (Nasdaq: SIBN) and previously served as Bruker's CFO-era executive in an earlier career
Alcoa Chairman Steven W. Williams notified the company on February 20, 2025, that he will not seek re-election to the Board at the 2025 Annual Meeting of Stockholders. He will remain chairman until his term ends at that meeting, and the filing says the decision is not due to any disagreement with the Board or the company. Board size will shrink to eleven directors after the meeting.
Steven W. Williams will not stand for re-election at the 2025 Annual Meeting of Stockholders
Williams has served as a director since Alcoa's 2016 launch as a public company and as Chairman since 2021
Board size will be reduced to eleven directors immediately upon the end of his term
The filing states the departure is not due to any disagreement with the Board or the company
3M disclosed that Peter Gibbons, Group President of Enterprise Supply Chain, intends to retire, effective April 2, 2025. The filing does not name a successor or describe any compensation arrangements tied to the departure.
Peter Gibbons, Group President, Enterprise Supply Chain, announced his intention to retire.
Retirement is effective April 2, 2025.
The filing was signed by Kevin H. Rhodes, Executive Vice President, Chief Legal Affairs Officer, and Secretary, on February 21, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.